CANSINOBIO(06185.HK)

Company Encyclopedia

CANSINOBIO

06185.HK

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides.

1.220 T

06185.HKMarket value -Rank by Market Cap -/-

Financial Score

31/12/2025 Update

BiotechnologyIndustry

Industry Ranking23/53

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreC
- ROE-2.84%D
- Profit Margin-14.62%D
- Gross Margin82.15%A
Growth ScoreB
- Revenue YoY28.50%A
- Net Profit YoY80.48%A
- Total Assets YoY-9.88%E
- Net Assets YoY-3.95%D
Cash ScoreC
- Cash Flow Margin-684.22%E
- OCF YoY28.50%A
Operating ScoreE
- Turnover0.13E
Debt ScoreB
- Gearing Ratio32.46%B

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
香港中央结算(代理人)有限公司	39.55%	No Change	28/10/2025
Huihua Mao	9.5%	No Change	31/12/2024
Tao Zhu	7.32%	No Change	31/12/2024
朱涛	7.27%	No Change	28/10/2025
XUEFENG YU(宇学峰)	7.26%	No Change	28/10/2025
Xuefeng Yu	7.28%	No Change	31/12/2024
Dongxu Qiu	6.94%	No Change	31/12/2024
DONGXU QIU(邱东旭)	6.92%	No Change	28/10/2025
HELEN HUIHUA MAO(毛慧华)	3.72%	No Change	28/10/2025
CHAMPDEN LLC	2.42%	No Change	28/10/2025

News

According to reports, pharmaceutical companies will raise the prices of 350 drugs in the United States next year, with an average increase of 4%

According to data from healthcare research firm 3 Axis Advisors, despite facing price reduction pressures from the U.S. government, pharmaceutical companies plan to raise the prices of at least 350 drugs next year, with an average increase of 4%. These drugs include COVID-19 vaccines, respiratory syncytial virus vaccines, shingles vaccines, and the blockbuster cancer treatment Ibrance. Compared to last year, the number of drug price increases planned for 2026 has increased, with over 250 drugs announced for price hikes last year

AASTOCKS·3 Hours ago